PSORIASIS Is ustekinumab superior to etanercept for psoriasis?

被引：6
|
作者：
Kuhn, Annegret [1 ]
Luger, Thomas A. [1 ]
机构：
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
来源：
NATURE REVIEWS RHEUMATOLOGY | 2010年 / 6卷 / 09期
关键词：
INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; TNF INHIBITION; TRIAL; EFFICACY; SAFETY;
D O I：
10.1038/nrrheum.2010.134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Both etanercept and ustekinumab have been shown to be strikingly effective in patients with psoriasis. A phase III trial comparing these two biologic agents for the treatment of moderate-to-severe psoriasis found that ustekinumab was superior to high-dose etanercept over a 12-week period; however, several questions remain to be addressed.
引用
收藏
页码：500 / 501
页数：3
相关论文
共 50 条
  • [11] The Safety of Ustekinumab in Psoriasis
    Famenini, Shannon
    Wu, Jashin J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (08) : 907 - 910
  • [12] Rapid response of scalp psoriasis to ustekinumab
    Di Cesare, Antonella
    Fargnoli, Maria Concetta
    Peris, Ketty
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (06) : 993 - 994
  • [13] Efficacy of Ustekinumab in Palmoplantar Psoriasis
    Livideanu, C. Bulai
    Lahfa, M.
    Mazereeuw-Hautier, J.
    Paul, C.
    DERMATOLOGY, 2010, 221 (04) : 321 - 323
  • [14] Long-term safety of ustekinumab for psoriasis
    Kumar, Neal
    Narang, Kirti
    Cressey, Brienne D.
    Gottlieb, Alice B.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (05) : 757 - 765
  • [15] Successful Treatment of Severe Psoriasis in an Adolescent with Ustekinumab
    AbuHilal, Mohn'd
    Ho, Nhung
    PEDIATRIC DERMATOLOGY, 2015, 32 (03) : 377 - 380
  • [16] Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis
    Ferrandiz, C.
    Garcia, A.
    Blasco, A. J.
    Lazaro, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (06) : 768 - 777
  • [17] Ustekinumab for the treatment of psoriasis
    Laws, Philip M.
    Warren, Richard B.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (02) : 155 - 164
  • [18] Ustekinumab in the treatment of palmoplantar pustular psoriasis - a case series of nine patients
    Buder, Valeska
    Herberger, Katharina
    Jacobi, Arnd
    Augustin, Matthias
    Radtke, Marc Alexander
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (11):
  • [19] Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis
    Scanlon, James V.
    Exter, Benjamin P.
    Steinberg, Michael
    Jarvis, Courtney I.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (09) : 1456 - 1465
  • [20] Exacerbation and Change of Psoriasis Morphology in a Patient Treated with Ustekinumab
    Kerdel, Francisco A.
    Valeron-Almazan, Pedro
    Vitiello, Magalys
    Abuchar, Adriana
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2011, 15 (03) : 183 - 184
12345